Nima Taefehshokr
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Immunotherapy and Immune Responses 3
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
-
- Cancer Immunotherapy and Biomarkers 3
- CAR-T cell therapy research 2
-
- Circular RNAs in diseases 3
- Co-authors
- Sina TaefehshokrBryan HeitBehzad BaradaranNima HemmatAlireza IsazadehNazila Fathi MaroufiAmir BaghbanzadehSaba Hajazimian
- Journals
- Biochemistry and Cell Biology (1 paper)Archivum Immunologiae et Therapiae Experimentalis (1 paper)FEBS Journal (1 paper)
- Partner nations
- IranCanadaUnited Kingdom
In The Last Decade
Nima Taefehshokr
21 papers receiving 604 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 137
- Immunology 185
- Infectious Diseases 115
- Oncology 156
- Molecular Biology 246
Countries citing papers authored by Nima Taefehshokr
This map shows the geographic impact of Nima Taefehshokr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nima Taefehshokr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nima Taefehshokr more than expected).
Fields of papers citing papers by Nima Taefehshokr
This network shows the impact of papers produced by Nima Taefehshokr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nima Taefehshokr. The network helps show where Nima Taefehshokr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nima Taefehshokr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 36 | |
| 7 | 2021 | 119 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 10 | |
| 10 | 2020 | 23 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 20 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 17 | |
| 16 | 2020 | 103 | |
| 17 | 2020 | 41 | |
| 18 | 2019 | 65 | |
| 19 | In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer. | 2019 | 61 |
| 20 | 2018 | 29 |
About Nima Taefehshokr
Nima Taefehshokr is a scholar working on Immunology, Cancer Research and Physiology, having authored 21 papers that have together received 613 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers), MicroRNA in disease regulation (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (137 citations), Immunology (185 citations) and Infectious Diseases (115 citations). Nima Taefehshokr has collaborated with scholars based in Iran, Canada and United Kingdom. Frequent co-authors include Sina Taefehshokr, Bryan Heit, Behzad Baradaran, Nima Hemmat, Alireza Isazadeh, Nazila Fathi Maroufi, Amir Baghbanzadeh, Saba Hajazimian, Mohammad‐Reza Rashidi and Mohammad Nouri. Their work appears in journals such as Biochemistry and Cell Biology, Archivum Immunologiae et Therapiae Experimentalis, FEBS Journal, Frontiers in Immunology and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.